Page last updated: 2024-09-05

eslicarbazepine acetate and Cognitive Dysfunction

eslicarbazepine acetate has been researched along with Cognitive Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andermann, E; Ben-Menachem, E; Benbadis, SR; Biraben, A; Biton, V; Blum, D; CarreƱo, M; Cheng, H; Gama, H; Rocha, F; Shah, AK; Shneker, B; Trinka, E1

Reviews

1 review(s) available for eslicarbazepine acetate and Cognitive Dysfunction

ArticleYear
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
    Epilepsy & behavior : E&B, 2018, Volume: 82

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Clinical Trials, Phase III as Topic; Cognitive Dysfunction; Depression; Depressive Disorder; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome

2018